
American Healthcare (AHR) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
540.6M
Gross Profit
108.2M
20.01%
Operating Income
40.3M
7.45%
Net Income
-6.8M
-1.27%
EPS (Diluted)
$-0.04
Balance Sheet Metrics
Total Assets
4.5B
Total Liabilities
2.2B
Shareholders Equity
2.3B
Debt to Equity
0.94
Cash Flow Metrics
Operating Cash Flow
36.9M
Free Cash Flow
39.4M
Revenue & Profitability Trend
American Healthcare Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 2.1B | 1.9B | 1.6B | 1.3B | 1.2B |
Cost of Goods Sold | 1.7B | 1.5B | 1.3B | 1.0B | 993.7M |
Gross Profit | 416.8M | 356.8M | 336.0M | 235.1M | 195.4M |
Gross Margin % | 20.1% | 19.2% | 20.8% | 18.6% | 16.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 100.8M | 105.0M | 103.1M | 81.9M | 59.3M |
Other Operating Expenses | - | -7.5M | -25.7M | -17.0M | -55.2M |
Total Operating Expenses | 100.8M | 97.5M | 77.4M | 65.0M | 4.1M |
Operating Income | 136.8M | 76.7M | 90.6M | 36.9M | 92.4M |
Operating Margin % | 6.6% | 4.1% | 5.6% | 2.9% | 7.8% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 127.7M | 163.2M | 106.0M | 80.9M | 71.3M |
Other Non-Operating Income | -42.9M | 10.2M | -57.4M | -8.3M | -15.3M |
Pre-tax Income | -33.9M | -76.2M | -72.8M | -52.3M | 5.8M |
Income Tax | 1.7M | 663.0K | 586.0K | 956.0K | -3.1M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | -53.2% |
Net Income | -35.6M | -76.9M | -73.4M | -53.3M | 8.9M |
Net Margin % | -1.7% | -4.1% | -4.5% | -4.2% | 0.7% |
Key Metrics | |||||
EBITDA | 362.9M | 320.6M | 315.2M | 194.8M | 219.1M |
EPS (Basic) | $-0.29 | $-1.08 | $-1.23 | $-0.72 | $0.03 |
EPS (Diluted) | $-0.29 | $-1.08 | $-1.23 | $-0.72 | $0.03 |
Basic Shares Outstanding | 130637539 | 66047114 | 66211989 | 66210308 | 66047114 |
Diluted Shares Outstanding | 130637539 | 66047114 | 66211989 | 66210308 | 66047114 |
Income Statement Trend
American Healthcare Balance Sheet From 2021 to 2024
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Assets | ||||
Current Assets | ||||
Cash & Equivalents | 76.7M | 43.4M | 65.1M | 81.6M |
Short-term Investments | - | - | - | - |
Accounts Receivable | 211.1M | 185.4M | 137.5M | 122.8M |
Inventory | 19.5M | 19.5M | 19.8M | 18.9M |
Other Current Assets | - | 33.2M | 25.9M | 22.5M |
Total Current Assets | 354.9M | 297.1M | 269.2M | 267.2M |
Non-Current Assets | ||||
Property, Plant & Equipment | 164.0M | 227.8M | 276.3M | 158.2M |
Goodwill | 631.4M | 650.4M | 699.5M | 668.7M |
Intangible Assets | 161.5M | 180.5M | 236.3M | 248.9M |
Long-term Investments | - | - | - | - |
Other Non-Current Assets | 100.9M | 104.6M | 99.1M | 86.6M |
Total Non-Current Assets | 4.1B | 4.3B | 4.5B | 4.3B |
Total Assets | 4.5B | 4.6B | 4.8B | 4.6B |
Liabilities | ||||
Current Liabilities | ||||
Accounts Payable | 258.3M | 242.9M | 243.8M | 187.3M |
Short-term Debt | 688.5M | 1.2B | 1.3B | 1.2B |
Current Portion of Long-term Debt | - | - | - | - |
Other Current Liabilities | - | - | - | - |
Total Current Liabilities | 946.9M | 1.5B | 1.5B | 1.4B |
Non-Current Liabilities | ||||
Long-term Debt | 1.2B | 1.6B | 1.6B | 1.3B |
Deferred Tax Liabilities | - | - | - | - |
Other Non-Current Liabilities | 54.9M | 82.2M | 60.4M | 61.3M |
Total Non-Current Liabilities | 1.2B | 1.7B | 1.6B | 1.3B |
Total Liabilities | 2.2B | 3.1B | 3.1B | 2.8B |
Equity | ||||
Common Stock | 1.6M | 661.0K | 661.0K | 658.0K |
Retained Earnings | -1.5B | -1.3B | -1.1B | -951.3M |
Treasury Stock | - | - | - | - |
Other Equity | - | - | - | - |
Total Shareholders Equity | 2.3B | 1.5B | 1.6B | 1.8B |
Key Metrics | ||||
Total Debt | 1.9B | 2.8B | 2.8B | 2.5B |
Working Capital | -592.0M | -1.2B | -1.3B | -1.1B |
Balance Sheet Composition
American Healthcare Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -35.6M | -76.9M | -73.4M | -53.3M | 8.9M |
Depreciation & Amortization | 221.6M | 237.3M | 200.6M | 157.4M | 129.6M |
Stock-Based Compensation | 9.9M | 5.5M | 3.9M | 9.7M | -1.2M |
Working Capital Changes | -68.7M | -51.5M | -52.0M | -131.3M | 123.8M |
Operating Cash Flow | 124.0M | 110.9M | 72.6M | -19.8M | 252.2M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | -235.0K | -12.9M | -18.6M | -650.0K | -960.0K |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | 29.8M | -27.8M | -21.6M | 17.2M | -1.6M |
Financing Activities | |||||
Share Repurchases | -14.0K | -469.0K | -20.7M | -382.0K | -23.1M |
Dividends Paid | -120.9M | -76.3M | -51.1M | -22.8M | -27.0M |
Debt Issuance | 954.3M | 578.2M | 1.3B | 349.6M | 216.1M |
Debt Repayment | -1.9B | -595.8M | -1.2B | -203.3M | -174.0M |
Financing Cash Flow | -134.7M | -187.0M | 13.1M | -11.8M | 18.9M |
Free Cash Flow | 84.1M | -1.3M | 76.2M | -61.8M | 90.9M |
Net Change in Cash | 19.0M | -103.9M | 64.1M | -14.4M | 269.5M |
Cash Flow Trend
American Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-140.93
Forward P/E
215.16
Price to Book
2.78
Price to Sales
3.22
PEG Ratio
-0.28
Profitability Ratios
Profit Margin
-1.53%
Operating Margin
8.33%
Return on Equity
-1.41%
Return on Assets
2.12%
Financial Health
Current Ratio
1.61
Debt to Equity
69.74
Per Share Data
EPS (TTM)
$-0.25
Book Value per Share
$14.71
Revenue per Share
$14.16
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ahr | 6.9B | -140.93 | 2.78 | -1.41% | -1.53% | 69.74 |
Welltower | 109.0B | 91.01 | 3.02 | 3.45% | 12.18% | 47.36 |
Ventas | 28.9B | 194.30 | 2.52 | 1.38% | 2.82% | 108.90 |
CareTrust REIT | 7.4B | 27.53 | 2.03 | 8.28% | 58.90% | 34.75 |
Healthcare Realty | 5.9B | 39.90 | 1.20 | -7.52% | -32.94% | 102.02 |
Sabra Health Care | 4.4B | 24.29 | 1.63 | 6.66% | 24.84% | 91.74 |
Financial data is updated regularly. All figures are in the company's reporting currency.